Author Archives

Recent Author Comments

On Microblog: A Non-Statin Pill That Really Lowers Cholesterol, Blood Pressure and Inflammation without Side Effects Would be a Good Investment, Right?
Dr. KSS. It is a informative and linguistic blessing to find your articles. Thank you. I wonder if I may ask you what do you thing of the notion that blood types have different food reactions. Dr. Peter D'Adamo comes to mind. Many thanks.[...]
On Microblog: A Non-Statin Pill That Really Lowers Cholesterol, Blood Pressure and Inflammation without Side Effects Would be a Good Investment, Right?
One method that has proved very effective in gum inflammation control/cure is brushing with baking powder (in some water to make a paste) and, once or twice per week, rinsing with a half/half peroxide and water. I have been doing it for years. Perfect gums[...]
On Microblog: PHOT
Thanks a million for your suggestion and input.[...]
On Microblog: Will PCSK9 Inhibitors Be the Next Blockbusters in Cardiovascular Disease?
"Now, there’s evidence that what saturated fats do is increase the levels of the larger LDL-C particles, which don’t appear to be particularly harmful. It’s the smaller, denser LDL-C that most contributes to atherosclerosis, and those are more relate[...]
On Microblog: In A Brutal Biotech Market, A Reason to Be Excited: Introducing Regado Biosciences
I love this site. The education one gets is invaluable. Thanks Dr. KSS and thanks to all who commented. I am forever a grateful reader and student.[...]
On Microblog: From the Motley Fool
I thought so too. What about SWIR? That was another one pitched.[...]
On Friday File: Cabot's #1 China Pick, Altius, and more...
I just checked ATUSF and it shows an EPS of -0.22 (Yahoo Finance). Does it worry you? I am not sure that the question is pertinent or even intelligent as I am quite new at investing. I signed up to your Irregulars because it is the most instructive site f[...]
On Microblog: NASH: An All-Too-Common Liver Disease and a Company Aiming to Treat It
THANKS a million for an informative article. You go well beyond the strictly financial perspective. What a blessing to have experts like you, enlighten us about these complex physiological processes in a clear and concise language.[...]
On A Biotech Trading Experiment ...
I would greatly appreciate your opinion on BIOL, ERB, SNTI. Thank you[...]
On $82 billion opportunity disappearing soon? (Frank Curzio's Phase 1)
I am an occasional but very interested and grateful reader of yours. I love the depth of your analysis. I also live in New Zealand at the moment. I would like to report this article on the subject:[...]

This site and Stock Gumshoe publications and authors do not offer individual financial, investment, medical or other advice. Nothing on this site should ever be considered to be personal advice, research or an invitation to buy or sell any securities. We also make mistakes and bad decisions sometimes, and our reasoning or data should be checked against trusted sources before they inform your investing decisions. Choices regarding how to invest your money or otherwise manage your life or finances are yours, we share only our analysis and opinion and all authors or commenters are individually responsible for the words and opinions they share here. Please read our important disclaimers and policies. Stock Gumshoe is supported by subscribers and by sponsors and advertisers. Stock Gumshoe's employee authors will disclose holdings in any stock covered at time of publication and will not trade in any stocks written about for at least three days after publication. Please see below for complete disclosure, disclaimer and policy information.

Connect with Travis

website designed by Gravity Switch